Black Rock Inc. Ultragenyx Pharmaceutical Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Black Rock Inc. holds 5,603,352 shares of RARE stock, worth $251 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

5,603,352

Previous 5,235,738 7.02%

Holding current value

$251 Million

Previous $244 Million 5.79%

% of portfolio

0.01%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$37.42 - $51.61 $13.8 Million - $19 Million	367,614 Added 7.02%	5,603,352 $230 Million
Q1 2024 May 10, 2024	SELL	$43.02 - $53.69 $114,519 - $142,922	-2,662 Reduced 0.05%	5,235,738 $244 Million
Q4 2023 Feb 13, 2024	BUY	$31.73 - $49.19 $5.05 Million - $7.83 Million	159,191 Added 3.13%	5,238,400 $251 Million
Q3 2023 Nov 13, 2023	BUY	$34.92 - $46.66 $425,395 - $568,412	12,182 Added 0.24%	5,079,209 $181 Million
Q2 2023 Aug 11, 2023	BUY	$37.35 - $52.15 $7.23 Million - $10.1 Million	193,671 Added 3.97%	5,067,027 $234 Million
Q1 2023 May 12, 2023	BUY	$36.99 - $48.71 $19.8 Million - $26.1 Million	536,513 Added 12.37%	4,873,356 $195 Million
Q4 2022 Feb 13, 2023	BUY	$33.72 - $46.33 $13.8 Million - $19 Million	409,204 Added 10.42%	4,336,843 $201 Million
Q3 2022 Nov 14, 2022	BUY	$39.96 - $66.14 $13.2 Million - $21.8 Million	330,055 Added 9.17%	3,927,639 $163 Million
Q2 2022 Aug 12, 2022	BUY	$45.8 - $85.4 $7.19 Million - $13.4 Million	156,913 Added 4.56%	3,597,584 $215 Million
Q1 2022 May 12, 2022	SELL	$62.2 - $84.4 $2.74 Million - $3.71 Million	-43,981 Reduced 1.26%	3,440,671 $250 Million
Q4 2021 Feb 10, 2022	BUY	$73.71 - $87.86 $2.51 Million - $3 Million	34,099 Added 0.99%	3,484,652 $293 Million
Q3 2021 Nov 09, 2021	SELL	$77.92 - $102.4 $3.22 Million - $4.24 Million	-41,388 Reduced 1.19%	3,450,553 $311 Million
Q2 2021 Aug 11, 2021	BUY	$92.19 - $115.71 $322 Million - $404 Million	3,491,941 New	3,491,941 $333 Million

Others Institutions Holding RARE

# of Institutions

325

Shares Held

85.7M

Call Options Held

520K

Put Options Held

406K

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.13B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account